REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Revenue, 2025
- $14.3B
- YoY, 2025
- +1.0%
- 5-year CAGR
- +11.0%
- 10-year CAGR
- +13.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $14.3B | +1.0% |
| 2024 | $14.2B | +8.3% |
| 2023 | $13.1B | +7.8% |
| 2022 | $12.2B | −24.3% |
| 2021 | $16.1B | +89.1% |
| 2020 | $8.5B | +29.6% |
| 2019 | $6.6B | +27.4% |
| 2018 | $5.1B | −12.4% |
| 2017 | $5.9B | +20.8% |
| 2016 | $4.9B | +18.4% |
| 2015 | $4.1B | +45.5% |
| 2014 | $2.8B | +34.0% |
| 2013 | $2.1B | +52.7% |
| 2012 | $1.4B | +209.2% |
| 2011 | $446M | −2.9% |
| 2010 | $459M | +21.0% |
| 2009 | $379M | +59.1% |
| 2008 | $238M | — |